Cathepsin D expression in chronic plaque psoriasis: An immunohistochemical study

Show simple item record

dc.contributor.author Abdou A.G.
dc.contributor.author Maraee A.H.
dc.contributor.author Shoeib M.A.E.
dc.contributor.author Elsammie A.A.A.
dc.contributor.author Elnaidany N.F.
dc.contributor.other Pathology Department
dc.contributor.other Menofiya University
dc.contributor.other Shebein Elkom
dc.contributor.other Egypt; Dermatology and Andrology Department
dc.contributor.other Faculty of Medicine
dc.contributor.other Menofiya University
dc.contributor.other Shebein Elkom
dc.contributor.other Egypt; Clinical Pharmacy Department
dc.contributor.other Faculty of Pharmacy
dc.contributor.other MSA University
dc.contributor.other October City
dc.contributor.other Egypt
dc.date.accessioned 2020-01-25T19:58:29Z
dc.date.available 2020-01-25T19:58:29Z
dc.date.issued 2011
dc.identifier.issn 1330027X
dc.identifier.other https://doi.org/
dc.identifier.uri https://t.ly/2ddPR
dc.description Scopus
dc.description.abstract Cathepsins are lysosomal cysteine proteases, which are involved in a variety of physiologic processes such as proenzyme activation, antigen presentation, tissue remodeling, bone matrix resorption, and pathologic processes such as facilitating tumor invasion and modulating the process of programmed cell death. This study aimed to evaluate the pattern of cathepsin D (CD) expression in chronic plaque psoriasis in comparison to normal skin by means of immunohistochemistry. The study included 34 patients presenting with chronic plaque psoriasis and 10 ageand sex-matched normal subjects as control group. Sixty percent of normal skin showed granular positivity for CD confined to basal layer. CD is upregulated in psoaritic lesion with 94.1% positivity making a significant difference between psoriasis and normal skin as regards the percentage and distribution of CD expression, where the latter was predominantly diffuse in psoriatic lesion. The eight cases exposed to PUVA therapy showed reduction of CD positivity to 62.5% with a predominance of mild staining and focal expression compared to pretreatment biopsies. CD may have a role in the pathogenesis of psoriasis in view of its high percentage and diffuse expression in psoriatic epidermis. CD degradative capacity may be responsible for disordered differentiation and scale formation characteristic of psoriasis. Reduction of CD expression may be one of the pathways of PUVA mechanism of action. en_US
dc.description.uri https://www.scimagojr.com/journalsearch.php?q=24217&tip=sid&clean=0
dc.language.iso English en_US
dc.relation.ispartofseries Acta Dermatovenerologica Croatica
dc.relation.ispartofseries 19
dc.subject Cathepsin D en_US
dc.subject Immunohistochemistry en_US
dc.subject Proteases en_US
dc.subject Psoriasis en_US
dc.subject cathepsin D en_US
dc.subject methoxsalen en_US
dc.subject adolescent en_US
dc.subject adult en_US
dc.subject aged en_US
dc.subject article en_US
dc.subject child en_US
dc.subject chronic disease en_US
dc.subject chronic psoriasis vulgaris en_US
dc.subject clinical article en_US
dc.subject controlled study en_US
dc.subject female en_US
dc.subject human en_US
dc.subject human tissue en_US
dc.subject immunohistochemistry en_US
dc.subject male en_US
dc.subject protein expression en_US
dc.subject psoriasis vulgaris en_US
dc.subject PUVA en_US
dc.subject school child en_US
dc.subject skin biopsy en_US
dc.subject Adolescent en_US
dc.subject Adult en_US
dc.subject Aged en_US
dc.subject Cathepsin D en_US
dc.subject Child en_US
dc.subject Chronic Disease en_US
dc.subject Female en_US
dc.subject Humans en_US
dc.subject Immunohistochemistry en_US
dc.subject Male en_US
dc.subject Middle Aged en_US
dc.subject Psoriasis en_US
dc.subject PUVA Therapy en_US
dc.subject Skin en_US
dc.subject Young Adult en_US
dc.title Cathepsin D expression in chronic plaque psoriasis: An immunohistochemical study en_US
dc.type Article en_US
dcterms.isReferencedBy Stuart, P., Malick, F., Nair, R.P., Henseler, T., Lim, H.W., Jenisch, S., Analysis of phenotypic variation in psoriasis as a function of age at onset and family history (2002) Arch Dermatol Res, 294, pp. 207-213; Krueger, G.G., Langley, R.G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis (2007) N Engl J Med, 356, pp. 580-592; Dickinson, D.P., Cysteine peptidases of mammals: Their biological roles and potential effects in the oral cavity and other tissues in health and disease (2002) Crit Rev Oral Biol Med, 13, pp. 238-275; Turk, B., Stoka, V., Rozman-Pungercar, J., Cirman, T., Droga-Mazovec, G., Oreic, K., Apoptotic pathways: Involvement of lysosomal proteases (2002) Biol Chem, 383, pp. 1035-1044; Hopkins, A.L., Groom, C.R., The druggable genome (2002) Nat Rev Drug Discov, 1, pp. 727-730; Tang, J., Wong, R.N., Evolution in the structure and function of aspartic proteases (1987) J Cell Biochem, 33, pp. 53-63; Hsueh, W.A., Baxter, J.D., (1991) Human Prorenin. Hypertension, 17, pp. 469-477; Sato, K., Waguri, S., Nitatori, T., Kon, S., Kominami, E., Watanabe, T., Immunocytochemical localization of lysosomal cysteine and aspartatic proteinases, and ubiquitin in rat epidermis (1997) Arch Histol Cytol, 30, pp. 275-287; Kawada, A., Hara, K., Kominami, E., Hiruma, M., Noguchi, H., Ishibashi, A., Processing of cathepsins L, B and D in psoriatic epidermis (1997) Arch Dermatol Res, 289, pp. 87-93; Horikoshi, T., Igarishi, S., Uchiwa, H., Brysk, H., Brysk, M.M., Role of endogenous cathepsin D-like and chymotrypsin-like proteolysis in human epidermal desquamation (1999) Br J Dermatol, 141, pp. 453-459; Serre, G., Mils, V., Haftek, M., Vincent, C., Croute, F., R�ano, A., Identification of late differentiation antigens of human cornified epithelia, expressed in reorganized desmosomes and bound to cross-linked envelope (1991) J Invest Dermatol, 97, pp. 1061-1072; Igarashi, S., Takizawa, T., Takizawa, T., Yasuda, Y., Uchiwa, H., Hayashi, S., Cathepsin D, but not cathepsin E, degrades desmosomes during epidermal desquamation (2004) Br J Dermatol, 151, pp. 355-361; Lazarus, G.S., Poole, R., Immunocytochemical localization of cathepsin D in rabbit skin (1975) Arch Dermatol, 111, pp. 1150-1153; Horikoshi, T., Arany, I., Rajaraman, S., Chen, S.-H., Brysk, H., Lei, G., Isoforms of cathepsin D and human epidermal differentiation (1998) Biochimie (Paris), 80, pp. 605-612; Egberts, F., Heinrich, M., Jensen, J.M., Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation (2004) J Cell Sci, 117, pp. 2295-2307; Vashishta, A., Saraswat Ohri, S., Vetvickova, J., Fusek, M., Ulrichova, J., Vetvicka, V., Procathepsin D secreted by HaCaT keratinocyte cells - a novel regulator of keratinocyte growth (2007) Eur J Cell Biol, 86, pp. 303-313; Rice, R.H., Green, H., Presence in human epidermal cells of a soluble protein precursor of the crosslinked envelope: Activation of the cross-linking by calcium ions (1979) Cell, 18, pp. 681-694; Dover, R., Watt, F.M., Measurement of the rate of epidermal terminal differentiation: Expression of involucrin by S-phase keratinocytes in culture and in psoriatic plaques (1987) J Invest Dermatol, 89, pp. 349-352; Watt, F.M., Boukamp, P., Hornung, J., Fusenig, N.E., Effect of growth environment on spatial expression of involucrin by human epidermal keratinocytes (1987) Arch Dermatol Res, 279, pp. 335-340; Negi, M., Matsui, T., Ogawa, H., Mechanism of human epidermal transglutaminase (1981) J Invest Dermatol, 77, pp. 389-392; Chen, S.H., Arany, I., Apisarnthanarax, N., Rajaraman, S., Tyring, S.K., Horikoshi, T., Response of keratinocytes from normal and psoriatic epidermis to interferon- gamma differs in the expression of zincalpha(2)-glycoprotein and cathepsin D (2000) FASEB J, 14, pp. 565-571; Minarowska, A., Gacko, M., Karwowska, A., Minarowski, L., Human cathepsin D (2008) Folia Histochem Cytobiol, 46, pp. 23-38; Berchem, G.J., Glondu, M., Gleizes, M., Brouillet, J.P., Garcia, M., Liaudet-Coopman, E., Cathepsin-D affects multiple steps of tumor progression: Proliferation, angiogenesis and apoptosis (2002) Oncogene, 21, pp. 5951-5955; Abdou, A.G., Hanout, H.M., Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study (2008) J Cutan Pathol, 35, pp. 445-451; Gonzlez-Vela, M.C., Garijo, M.F., Fernndez, F., Buelta, L., Val-Bernal, J.F., Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma (1999) Histopathology, 34, pp. 35-42; Lsch, A., Schindl, M., Kohlberger, P., Lahodny, J., Breitenecker, G., Horvat, R., Cathepsin D in ovarian cancer: Prognostic value and correlation with p53 expression and microvessel density (2004) Gynecol Oncol, 92, pp. 545-552; Briozzo, P., Badet, J., Capony, F., Pieri, I., Montcourrier, P., Barritault, D., MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: A permissive role of cathepsin D (1991) Exp Cell Res, 194, pp. 252-259; Piwnica, D., Fernandez, I., Binart, N., Touraine, P., Kelly, P.A., Goffin, V., A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D (2006) Mol Endocrinol, 20, pp. 3263-3278; Vallat, V.P., Gilleaudeau, P., Battat, L., Wolfe, J., Nabeya, R., Heftler, N., PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: A possible cellular basis for remittive therapy (1994) J Exp Med, 180, pp. 283-296
dcterms.source Scopus
dc.identifier.doi https://doi.org/
dc.Affiliation October University for modern sciences and Arts (MSA)


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search MSAR


Advanced Search

Browse

My Account